Current Bladder Dysfunction Reports

, Volume 8, Issue 1, pp 51–56 | Cite as

Medical Causes of Overactive Bladder

Overactive Bladder (A Klausner, Section Editor)
  • 189 Downloads

Abstract

Overactive bladder (OAB), defined as a symptom complex consisting of urgency, with or without urge incontinence, in the absence of urinary tract infection or other obvious pathology, is a diagnosis affecting millions of Americans and patients around the world and is associated with significant secondary morbidity and mortality. The economic burden and prevalence of OAB is increasing in the United States, and its underlying etiology can be attributed to multiple factors. In addition to aging, pelvic floor weakness and bladder outlet obstruction, a number of medical conditions can lead to the symptoms of overactive bladder. Recognition and proper management of associated medical conditions can lead to improved patient outcomes and decreased expenditure of healthcare resources.

Keywords

Overactive bladder Detrusor overactivity Neurogenic bladder Incontinence 

Notes

Disclosure

No potential conflicts of interest relevant to this article were reported.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    • Haylen BT, de Ridder D, Freeman RM, et al.: An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;5–26. A understanding of the definition of overactive bladder is important when reviewing relevant literature. Google Scholar
  2. 2.
    Abrams P, Cardozo L, Fall M, et al. The standardization of terminology in lower urinary tract function: report from the standardization subcommittee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.PubMedCrossRefGoogle Scholar
  3. 3.
    Abrams P, Blaivas JG, Stanton S, et al. The standardization of terminology of lower urinary tract function. Neurourol Urodyn. 1988;7:403–26.CrossRefGoogle Scholar
  4. 4.
    Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–14.PubMedCrossRefGoogle Scholar
  5. 5.
    • Tikkinen KA. Epidemiology of Nocturia - Results from the FINNO Study. Tampere University Press. 2010. Prevalence of OAB must be considered in the context of any underlying pathology. Google Scholar
  6. 6.
    Ganz ML, Smalarz AM, Krupski TL, et al. Economic costs of overactive bladder in the United States. Urology. 2010;75(3):526–32.PubMedCrossRefGoogle Scholar
  7. 7.
    • Robinson D, Cardozo L. Overactive bladder: diagnosis and management. Maturitas. 2012;71(2):188–93. Article discusses the difference between overactive bladder and detrusor overactivity.PubMedCrossRefGoogle Scholar
  8. 8.
    Hashim H, Abrams P: Is the bladder a reliable witness for predicting detrusor overactivity? J Urol. 2006.191–195.Google Scholar
  9. 9.
    Brown JS. Diabetic Cystopathy—What Does it Mean? J Urol. 2009;181(1):13–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Lee WC, Wu HP, Tai TY, et al. Effects of Diabetes on Female Voiding Behavior. J Urol. 2004;172(3):989–92.PubMedCrossRefGoogle Scholar
  11. 11.
    Yamaguchi C, Sakakibara R, Uchiyama T, et al. Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodyn. 2007;26(6):807–13.PubMedCrossRefGoogle Scholar
  12. 12.
    Liu RT, Chung MS, Lee WC, et al. Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes. Urology. 2011;78(5):1040–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Chiu AF, Huang MH, Wang CC, Kuo HC. Higher glycosylated hemoglobin levels increase the risk of overactive bladder syndrome in patients with type 2 diabetes mellitus. Int J Urol. 2012. 10.1111/j.1442-2042.2012.03095.x.Google Scholar
  14. 14.
    Grünfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol. 2009;5(5):270–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Rosenbaum JF, Pollack MH. Treatment-emergent incontinence with lithium. J Clin Psych. 1985;46(10):444–5.Google Scholar
  16. 16.
    Fry CH, et al.: Incontinence. Abrams P, Cardozo L, Khoury S, Wein A, editors. Health Publications. 2005;313–362.Google Scholar
  17. 17.
    de Groat WC, Booth AM. Nervous Control of the Urogenital System (Autonomic Nervous System). Harwood Academic. 1993;291–347.Google Scholar
  18. 18.
    Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev. 2004;84(3):935–86.PubMedCrossRefGoogle Scholar
  19. 19.
    Janig W, Morrison JF. Functional properties of spinal visceral afferents supplying abdominal and pelvic organs, with special emphasis on visceral nociception. Prog Brain Res. 1986;87–114.Google Scholar
  20. 20.
    Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453–66.PubMedCrossRefGoogle Scholar
  21. 21.
    Tubaro A, Puccini F, De Nunzio C, et al. The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review. Curr Urol Rep. 2012;13(5):335–42.PubMedCrossRefGoogle Scholar
  22. 22.
    Betts CD, D’Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psych. 1993;245–250Google Scholar
  23. 23.
    • Wolfe DL, Legassic M, McIntyre A, et al.: Bladder Health and Function Following Spinal Cord Injury. Spinal Cord Inj Rehabil Evid. 2012;1–143. It is important to consider the urologic symptoms expected based on the level of spinal cord lesion. Google Scholar
  24. 24.
    Betts CD, D’Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neural Neurosurg Psychiatry. 1993;245–250Google Scholar
  25. 25.
    Onal B, Siva A, Buldu I, et al. Voiding Dysfunction due to Multiple Sclerosis: a Large Scale Retrospective Analysis. Int Braz J Urol. 2009;35(3):326–33.PubMedCrossRefGoogle Scholar
  26. 26.
    Kasabian NG, Krause I, Brown WE, et al. Fate of the upper urinary tract in multiple sclerosis. Neurourol Urodyn. 1995;14(1):81–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Hall SA, Curto TM, Onyenwenyi A, et al.: Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the Boston Area Community Health (BACH) survey. Neurourol Urodyn. 2012;1149–55.Google Scholar
  28. 28.
    Winge K, Nielsen KK. Bladder dysfunction in advanced parkinson's disease. Neurourol Urodyn. 2012;31(8):1279–83.PubMedCrossRefGoogle Scholar
  29. 29.
    Iacovelli E, Gilio F, Meco G, et al. Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease. Mov Disord. 2010;25(9):1203–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Ragab MM, Mohammed ES. Idiopathic Parkinson's disease patients at the urologic clinic. Neurourol Urodyn. 2011;30(7):1258–61.PubMedGoogle Scholar
  31. 31.
    Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord. 2002;17(5):867–76.PubMedCrossRefGoogle Scholar
  32. 32.
    Ahmed HU, Shergill IS, Arya M, Shah PJ. Management of detrusor-external sphincter dyssynergia. Nat Clin Pract Urol. 2006;3(7):368–80.PubMedCrossRefGoogle Scholar
  33. 33.
    Mahfouz W, Corcos J. Management of detrusor external sphincter dyssynergia in neurogenic bladder. Eur J Phys Rehabil Med. 2011;47(4):639–50.PubMedGoogle Scholar
  34. 34.
    Cruz CD, Cruz F. Spinal cord injury and bladder dysfunction: new ideas about an old problem. Sci World J. 2011;11:214–34.CrossRefGoogle Scholar
  35. 35.
    Erol B, Koçak T, Kadioğlu A, et al. The relationship between level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Ulus Travma Acil Cerrahi Derg. 2009;15(4):377–82.PubMedGoogle Scholar
  36. 36.
    Podnar S, Trsinar B, Vodusek DB. Bladder dysfunction in patients with cauda equina lesions. Neurourol Urodyn. 2006;25(1):23–31.PubMedCrossRefGoogle Scholar
  37. 37.
    Mehdizadeh M, Roohi A, Hemami M, Esfahani ST. Is There Any Association between Spina Bifida Occulta and Primary Vesicoureteral Reflux? Iranian J Ped. 2010;20(3):348–52.Google Scholar
  38. 38.
    de Jong TP, Chrzan R, Klijn AJ, Dik P. Treatment of the neurogenic bladder in spina bifida. Pediatr Nephrol. 2008;23(6):889–96.PubMedCrossRefGoogle Scholar
  39. 39.
    Sakakibara R, Hattori T, Uchiyama T, et al. Uroneurological assessment of spina bifida cystica and occulta. Neurourol Urodyn. 2003;22(4):328–34.PubMedCrossRefGoogle Scholar
  40. 40.
    Chandra MS. Can urodynamic studies be dispensed with in the initial urologic management of children with meningomyelocele? A study of 30 cases and review of the literature. J Ped Urol. 2007;3(3):195–9.CrossRefGoogle Scholar
  41. 41.
    Nitti VW, Adler H, Combs AJ. The role of urodynamics in the evaluation of voiding dysfunction in men after cerebrovascular accident. J Urol. 1996;155(1):263–6.PubMedCrossRefGoogle Scholar
  42. 42.
    Nakayama H, Jørgensen HS, Pedersen PM, et al. Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study. Stroke. 1997;28(1):58–62.PubMedCrossRefGoogle Scholar
  43. 43.
    Gupta A, Taly AB, Srivastava A, Thyloth M. Urodynamics post stroke in patients with urinary incontinence: Is there correlation between bladder type and site of lesion? Ann Indian Acad Neurol. 2009;12(2):104–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Kiefer M, Unterberg A. The differential diagnosis and treatment of normal-pressure hydrocephalus. Dtsch Arztebl Int. 2012;109(1–2):15–25.PubMedGoogle Scholar
  45. 45.
    Sakakibara R, Uchiyama T, Kanda T, et al. Urinary dysfunction in idiopathic normal pressure hydrocephalus. Brain Nerve. 2008;60(3):233–9.PubMedGoogle Scholar
  46. 46.
    • Sakakibara R, Uchida Y, Ishii K, et al. Correlation of right frontal hypoperfusion and urinary dysfunction in iNPH: a SPECT study. Neurourol Urodyn. 2012;31(1):50–5. Important study showing that in patients with NPH, urinary dysfunction correlates with right frontal lobe hypoperfusion. This study may help uncover the higher cortical centers involved in micturition.PubMedCrossRefGoogle Scholar
  47. 47.
    Greenberg BM. Treatment of acute transverse myelitis and its early complications. Continuum (Minneap Minn). 2011;17(4):733–43.Google Scholar
  48. 48.
    Pizzorno R, Simonato A, Esposito M, et al. Vesical sequelae of transverse myelitis. Long-term urodynamics observations in adult patients. Urologia. 2009;76(2):101–3.PubMedGoogle Scholar
  49. 49.
    Nakipoglu GF, Ozgirgin N. Urodynamic evaluation and rehabilitation outcomes in transverse myelitis. Neurosciences (Riyadh). 2009;14(1):37–40.Google Scholar
  50. 50.
    Tanaka ST, Stone AR, Kurzrock EA. Transverse myelitis in children: long-term urological outcomes. J Urol. 2006;175(5):1865–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Sakakibara R, Uchiyama T, Kuwabara S, et al. Prevalence and mechanism of bladder dysfunction in Guillain-Barré Syndrome. Neurourol Urodyn. 2009;28(5):432–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of UrologySUNY Downstate College of MedicineBrooklynUSA
  2. 2.SUNY Downstate College of MedicineBrooklynUSA

Personalised recommendations